HomeAI · summaries
Storia in 5 fonti
Novo’s weight-loss drug Wegovy gets CDSCO approval for fatty liver disease
The CDSCO has approved a new indication for Wegovy (semaglutide injection 2.4 mg) for treatment of noncirrhotic metabolic dysfunction associated steatohepatitis (MASH) in adults | India News
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss
Novo Nordisk wins EU approval for Wegovy pill, the first oral GLP-1 for weight management, backed by OASIS trial data.
- ·
economictimes.indiatimes.com
Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer
India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disease. The approval follows a committee…
